[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q3_USD":9187000.0,"OperatingIncomeLoss_1_Q3_USD":303052000.0,"OperatingIncomeLoss_3_Q3_USD":1277298000.0,"OtherAssetsCurrent_0_Q3_USD":8945000.0,"OtherAssetsNoncurrent_0_Q3_USD":4515000.0,"OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_1_Q3_USD":0.0,"OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_3_Q3_USD":0.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-14331000.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":-31971000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_1_Q3_USD":-6000000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_3_Q3_USD":-14112000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":-8331000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":-17859000.0,"OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_1_Q3_USD":11756000.0,"OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_3_Q3_USD":40545000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-2575000.0,"NotesReceivableNet_0_Q3_USD":14593862000.0,"NotesReceivableGross_0_Q3_USD":16022302000.0,"NotesAndLoansReceivableNetNoncurrent_0_Q3_USD":14014116000.0,"NotesAndLoansReceivableNetCurrent_0_Q3_USD":579746000.0,"MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1_Q3_USD":159714000.0,"MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_3_Q3_USD":475901000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":583183000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-1318634000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":1527579000.0,"NetIncomeLoss_1_Q3_USD":101929000.0,"NetIncomeLoss_3_Q3_USD":611824000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":8574000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q3_USD":119867000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":101929000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":611824000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q3_USD":144521000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_3_Q3_USD":905922000.0,"NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_3_Q3_USD":0.0,"NonoperatingIncomeExpense_1_Q3_USD":-81256000.0,"NonoperatingIncomeExpense_3_Q3_USD":-89768000.0,"NetIncomeLossAttributableToNoncontrollingInterest_3_Q3_USD":575706000.0,"OtherLiabilitiesCurrent_0_Q3_USD":0.0,"OtherNoncashIncomeExpense_3_Q3_USD":-3263000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-793000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":96263000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":2320878000.0,"Revenues_1_Q3_USD":585773000.0,"Revenues_3_Q3_USD":1713763000.0,"ShareBasedCompensation_3_Q3_USD":1939000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":10386634000.0,"StockholdersEquityOther_1_Q3_USD":0.0,"ResearchAndDevelopmentExpense_1_Q3_USD":90500000.0,"StockholdersEquityOther_3_Q3_USD":0.0,"StockIssuedDuringPeriodValueShareBasedCompensation_3_Q3_USD":1939000.0,"TradingSecuritiesDebt_0_Q3_USD":245745000.0,"TransferOfInvestments_3_Q3_USD":0.0,"TreasuryStockValue_0_Q3_USD":2685000.0,"UnrealizedGainLossOnDerivatives_3_Q3_USD":-21436000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":607174000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":607152000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":505000.0,"MinorityInterest_0_Q3_USD":4593564000.0,"RepaymentsOfLongTermDebt_3_Q3_USD":0.0,"ProvisionForLoanAndLeaseLosses_3_Q3_USD":186337000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-858000.0,"PaymentsOfDebtIssuanceCosts_3_Q3_USD":12245000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":52755000.0,"PaymentsToAcquireEquityMethodInvestments_3_Q3_USD":28320000.0,"PaymentsToAcquireFinanceReceivables_3_Q3_USD":2019768000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":755668000.0,"PaymentsToMinorityShareholders_3_Q3_USD":363624000.0,"ProvisionForLoanLossesExpensed_3_Q3_USD":-23343000.0,"ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_3_Q3_USD":523000.0,"ProceedsFromIssuanceInitialPublicOffering_3_Q3_USD":0.0,"ProceedsFromIssuanceOfLongTermDebt_3_Q3_USD":1272533000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":1493135000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_3_Q3_USD":46875000.0,"ProfitLoss_1_Q3_USD":221796000.0,"ProfitLoss_3_Q3_USD":1187530000.0,"ProvisionForLoanAndLeaseLosses_1_Q3_USD":137837000.0,"ProceedsFromInterestReceived_3_Q3_USD":3004000.0,"LongTermDebtNoncurrent_0_Q3_USD":7090669000.0,"LongTermDebtCurrent_0_Q3_USD":0.0,"LongTermDebt_0_Q3_USD":7090669000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":593965000.0,"CostsAndExpenses_1_Q3_USD":282721000.0,"CostsAndExpenses_3_Q3_USD":436465000.0,"DebtInstrumentUnamortizedDiscount_0_Q3_USD":209331000.0,"DebtSecuritiesAvailableForSaleUnrealizedGainLoss_1_Q3_USD":-14885000.0,"DebtSecuritiesAvailableForSaleUnrealizedGainLoss_3_Q3_USD":8246000.0,"DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_1_Q3_USD":42592000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":93598000.0,"DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_3_Q3_USD":294098000.0,"DividendsCash_3_Q3_USD":211581000.0,"DividendsCommonStockCash_3_Q3_USD":211600000.0,"DueToRelatedPartiesCurrent_0_Q3_USD":119135000.0,"DueToRelatedPartiesNoncurrent_0_Q3_USD":119135000.0,"EarningsPerShareBasic_1_Q3_USD":0.24,"EarningsPerShareBasic_3_Q3_USD":1.49,"EarningsPerShareDiluted_1_Q3_USD":0.24,"DividendsCash_1_Q3_USD":73017000.0,"EarningsPerShareDiluted_3_Q3_USD":1.49,"CommonStockDividendsPerShareCashPaid_3_Q3_USD":0.17,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":792128000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":20553000.0,"AdditionalPaidInCapital_0_Q3_USD":3454218000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":700000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":2400000.0,"AmortizationOfFinancingCostsAndDiscounts_3_Q3_USD":14822000.0,"AmortizationOfIntangibleAssets_1_Q3_USD":5796000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":17200000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"Assets_0_Q3_USD":17732358000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":63603000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":192097000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":255700000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":67016000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q3_USD":188684000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":1800808000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":1800808000.0,"AssetsCurrent_0_Q3_USD":2775761000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":428230000.0,"EquityMethodInvestmentDividendsOrDistributions_3_Q3_USD":28213000.0,"EquitySecuritiesFVNINoncurrent_0_Q3_USD":264765000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":-2138000.0,"IncreaseDecreaseInInterestPayableNet_3_Q3_USD":-25413000.0,"IncreaseDecreaseInOtherCurrentAssets_3_Q3_USD":473000.0,"IncrementalCommonSharesAttributableToContingentlyIssuableShares_1_Q3_shares":178942000.0,"IncrementalCommonSharesAttributableToContingentlyIssuableShares_3_Q3_shares":197881000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q3_shares":2000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3_Q3_shares":18000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":0.0,"InterestExpense_1_Q3_USD":44327000.0,"InterestPaidNet_3_Q3_USD":129759000.0,"InterestPayableCurrent_0_Q3_USD":16733000.0,"InvestmentIncomeNet_1_Q3_USD":12261000.0,"InvestmentIncomeNet_3_Q3_USD":42896000.0,"Liabilities_0_Q3_USD":7345724000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":17732358000.0,"LiabilitiesCurrent_0_Q3_USD":255055000.0,"InterestExpense_3_Q3_USD":119168000.0,"EquityMethodInvestments_0_Q3_USD":473051000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"IncomeLossFromEquityMethodInvestments_1_Q3_USD":2749000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_1_Q3_USD":-19289000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_3_Q3_USD":-17980000.0,"FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss_1_Q3_USD":-19300000.0,"FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss_3_Q3_USD":-30000000.0,"FinancingReceivableAllowanceForCreditLosses_0_Q3_USD":1428440000.0,"FinancingReceivableChangeInPresentValueExpenseReversal_3_Q3_USD":-21721000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":594750000.0,"IncomeLossFromEquityMethodInvestments_3_Q3_USD":18532000.0,"FiniteLivedIntangibleAssetsGross_0_Q3_USD":606216000.0,"GainLossOnDerivativeInstrumentsNetPretax_1_Q3_USD":-16972000.0,"GainLossOnDerivativeInstrumentsNetPretax_3_Q3_USD":-21436000.0,"GainsLossesOnExtinguishmentOfDebt_3_Q3_USD":-358000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":48588000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":136665000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":221796000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":1187530000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":11466000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":409253000.0,"Ticker":"RPRX","CIK":"1802768","name":"ROYALTY PHARMA PLC","OfficialName":"Royalty Pharma plc Class A Ordinary Shares ","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"19213987432.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211110"}]